AUSTIN, Texas, Oct. 12, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today issued the following statement regarding an internal report purportedly prepared by City University of New York (CUNY). This report was leaked to the press. The leak of the…Read More
Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press
